Artivion | CRY - Loan Capital


Artivion reported $363.42M in Loan Capital for its fiscal quarter ending in June of 2026.





Loan Capital Change Date
Abbott USD 29.64B 19.74B Mar/2026
Accuray USD 124.78M 2.54M Dec/2025
AngioDynamics USD 5.6M 100K Sep/2025
Artivion USD 363.42M 148.07M Jun/2026
AtriCure USD 61M 0 Jun/2026
Baxter International USD 8.62B 6M Jun/2026
Becton, Dickinson and Co. USD 13.51B 1.2B Jun/2026
Boston Scientific USD 10.86B 148M Mar/2026
Edwards Lifesciences USD 598.7M 1.3M Jun/2026
Inogen USD 0 0 Jun/2022
Integra LifeSciences USD 1.83B 2.05M Jun/2026
J&J USD 37.34B 183M Jun/2026
Mesa Laboratories USD 104.2M 104.3M Sep/2024
Orthofix International USD 221.59M 256K Jun/2026
Pfizer USD 60.5B 70M Jun/2026
ResMed USD 399.42M 4.75M Jun/2026
Stryker USD 14.19B 32M Jun/2026
Tandem Diabetes Care USD 602.58M 809K Jun/2026
Teleflex USD 2.72B 206.24M Jun/2026
Terumo JPY 209.52B 109.61B Jun/2026
Trinity Biotech USD 16.33M 98.53M Dec/2025